Giant cell myocarditis treated with long-term multi-modal care with multiple mechanical circulatory support: case report
Open Access
- 8 July 2026
- journal article
- case report
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (7) , omag110
Abstract
We report the case of a 71-year-old woman with giant cell myocarditis presenting as acute heart failure and cardiogenic shock (LVEF 15%). She required mechanical ventilation, IMPELLA CP (Abiomed, Danvers, MA), veno-arterial extracorporeal (VA-ECMO), and continuous renal replacement therapy. Endomyocardial biopsy confirmed giant cell myocarditis, and treatment with corticosteroids, mycophenolate mofetil, and tacrolimus was initiated. Following multi-modal support and immunosuppressive therapy, left ventricular function recovered to 54%, allowing withdrawal of mechanical circulatory support and hemodialysis. However, the patient ultimately died on the 111th day due to the long treatment of cytomegalovirus infection and septic shock from catheter-related blood stream infection. Optimal immunosuppressive regimens remain undefined, so this case highlights successful recovery of cardiac function with intensive multi-modal management.Keywords
This publication has 9 references indexed in Scilit:
- JCS/JSCVS/JCC/CVIT 2023 Guideline Focused Update on Indication and Operation of PCPS/ECMO/IMPELLACirculation Journal, 2024
- Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditisJournal of Cardiothoracic Surgery, 2022
- Management of Patients With Giant Cell MyocarditisJACC, 2021
- Management of Acute Myocarditis and Chronic Inflammatory CardiomyopathyCirculation: Heart Failure, 2020
- Recognition and Initial Management of Fulminant MyocarditisCirculation, 2020
- Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare CaseCase Reports in Cardiology, 2017
- Characteristics and Predictors of Mortality in Patients With Cardiovascular Shock in Japan – Results From the Japanese Circulation Society Cardiovascular Shock Registry –Circulation Journal, 2016
- Giant cell myocarditisHerz, 2012
- Idiopathic Giant-Cell Myocarditis — Natural History and TreatmentNew England Journal of Medicine, 1997